Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-24 @ 6:36 PM
NCT ID:
NCT03880357
Eligibility Criteria:
Inclusion Criteria:
* Healthy male or non-pregnant female aged ≥18 years
* All male subjects had to agree to use accepted methods of birth control with their partners, from the day of the first application of the study drug to 30 days after the last application of the study drug
* Willing and able to understand and comply with the requirements of the protocol, including attendance at the required study visits
* A clinical diagnosis of stable (at least 6 months) scalp psoriasis involving at least 10% of the scalp
Exclusion Criteria:
* Female subjects who were pregnant, nursing, or planning to become pregnant during study participation
* Known hypersensitivity to calcipotriene, betamethasone dipropionate, other corticosteroids, or to any ingredients in the study drugs
* Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic, exfoliative, or pustular psoriasis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03880357
Study Brief:
Protocol Section:
NCT03880357